Acute and subacute oral toxicity evaluation of Ayurvedic formulation Tapyadi loha in rats.

IF 2.1 4区 医学 Q3 CHEMISTRY, MULTIDISCIPLINARY Drug and Chemical Toxicology Pub Date : 2024-11-01 Epub Date: 2024-08-20 DOI:10.1080/01480545.2024.2389965
Piyush H Hinge, Mukul S Tambe, Prajakta H Murudkar, Akshay M Baheti, Chandrashekhar S Mote, S B Chandrasekar, Manasi R Nimbalkar, Anil T Pawar
{"title":"Acute and subacute oral toxicity evaluation of Ayurvedic formulation <i>Tapyadi loha</i> in rats.","authors":"Piyush H Hinge, Mukul S Tambe, Prajakta H Murudkar, Akshay M Baheti, Chandrashekhar S Mote, S B Chandrasekar, Manasi R Nimbalkar, Anil T Pawar","doi":"10.1080/01480545.2024.2389965","DOIUrl":null,"url":null,"abstract":"<p><p>Ayurveda is one of the oldest systems of traditional medicine that provides treatments for a wide range of acute and chronic health problems. It is a common myth amongst people that Ayurvedic drugs have no side effects, whereas the fact is that these drugs can cause adverse effects. Despite their wide use, the safety data of many Ayurvedic formulations are still unavailable. <i>Tapyadi loha</i> is an Ayurvedic formulation traditionally claimed for iron deficiency anemia in pregnant and non-pregnant patients. However, no scientific study has been conducted to evaluate its oral toxicity. Hence, the present study evaluated the acute and subacute oral toxicity of the <i>Tapyadi loha</i> according to the OECD test guidelines 425 and 407, respectively. <i>Tapyadi loha</i> did not cause mortality nor any signs of toxicity when given once orally at a dose of 2000 mg/kg. Subacute toxicity study showed no mortality as well as no behavioral, hematological, biochemical and histopathological abnormalities in rats treated with <i>Tapyadi loha</i> formulation at 250, 500 and 1000 mg/kg for 28 days. It is concluded that the <i>Tapyadi loha</i> is safe at a single dose of 2000 mg/kg and 28 days repeated dose of 1000 mg/kg by oral route in rats.</p>","PeriodicalId":11333,"journal":{"name":"Drug and Chemical Toxicology","volume":" ","pages":"1369-1381"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and Chemical Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/01480545.2024.2389965","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Ayurveda is one of the oldest systems of traditional medicine that provides treatments for a wide range of acute and chronic health problems. It is a common myth amongst people that Ayurvedic drugs have no side effects, whereas the fact is that these drugs can cause adverse effects. Despite their wide use, the safety data of many Ayurvedic formulations are still unavailable. Tapyadi loha is an Ayurvedic formulation traditionally claimed for iron deficiency anemia in pregnant and non-pregnant patients. However, no scientific study has been conducted to evaluate its oral toxicity. Hence, the present study evaluated the acute and subacute oral toxicity of the Tapyadi loha according to the OECD test guidelines 425 and 407, respectively. Tapyadi loha did not cause mortality nor any signs of toxicity when given once orally at a dose of 2000 mg/kg. Subacute toxicity study showed no mortality as well as no behavioral, hematological, biochemical and histopathological abnormalities in rats treated with Tapyadi loha formulation at 250, 500 and 1000 mg/kg for 28 days. It is concluded that the Tapyadi loha is safe at a single dose of 2000 mg/kg and 28 days repeated dose of 1000 mg/kg by oral route in rats.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿育吠陀配方 Tapyadi loha 对大鼠急性和亚急性口服毒性评估
阿育吠陀是最古老的传统医学体系之一,可治疗各种急性和慢性健康问题。人们普遍认为阿育吠陀药物没有副作用,但事实上这些药物可能会产生不良反应。尽管阿育吠陀药物被广泛使用,但许多阿育吠陀配方的安全性数据仍未公布。Tapyadi loha 是一种阿育吠陀配方,传统上用于治疗孕妇和非孕妇缺铁性贫血。然而,还没有科学研究对其口服毒性进行评估。因此,本研究根据经合组织测试指南 425 和 407,分别对 Tapyadi loha 的急性和亚急性口服毒性进行了评估。在口服一次 2000 毫克/千克的剂量时,Tapyadi loha 不会导致死亡,也不会出现任何中毒症状。亚急性毒性研究表明,大鼠在服用 250、500 和 1000 毫克/千克剂量的 Tapyadi loha 制剂 28 天后,未出现死亡以及行为、血液学、生化和组织病理学异常。结论是,大鼠口服 Tapyadi loha,单次剂量为 2000 毫克/千克,28 天重复剂量为 1000 毫克/千克,是安全的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug and Chemical Toxicology
Drug and Chemical Toxicology 医学-毒理学
CiteScore
6.00
自引率
3.80%
发文量
99
审稿时长
3 months
期刊介绍: Drug and Chemical Toxicology publishes full-length research papers, review articles and short communications that encompass a broad spectrum of toxicological data surrounding risk assessment and harmful exposure. Manuscripts are considered according to their relevance to the journal. Topics include both descriptive and mechanics research that illustrates the risk assessment implications of exposure to toxic agents. Examples of suitable topics include toxicological studies, which are structural examinations on the effects of dose, metabolism, and statistical or mechanism-based approaches to risk assessment. New findings and methods, along with safety evaluations, are also acceptable. Special issues may be reserved to publish symposium summaries, reviews in toxicology, and overviews of the practical interpretation and application of toxicological data.
期刊最新文献
Mitigative and neuroprotective effects of Lavandula angustifolia essential oil on serotonin syndrome-induced neurotoxicity in male albino rats. Effect of adenosine triphosphate on methylphenidate-induced oxidative and inflammatory kidney damage in rats. Pre-clinical acute oral toxicity and subacute neurotoxicity risk assessments on sprague dawley rats treated with single dose or repeated doses of flavonoid-enriched fraction extracted from Oroxylum indicum leaves. In silico molecular docking and in vitro analysis of atomoxetine. Humic acid attenuates cisplatin-induced nephrotoxicity in rats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1